FermaVir's Founder and Board Member Professor Chris McGuigan receives the Royal Society of Chemistry's Award for Medicinal Chemistry
16th Nov 2006, 08:21 GMT
FermaVir Pharmaceuticals, announced that the Royal Society of Chemistry will present Professor Chris McGuigan the society's award for Medicinal Chemistry on the 17th of November at their awards dinner in Glasgow.
FermaVir's Founder and Board Member Professor Chris McGuigan receives the Royal Society of Chemistry's Award for Medicinal Chemistry related news:
- USC's Gatz Wins The Gerontological Society Of America's 2006 Donald P. Kent Award — Health News from Medical News Today
- Annual Black History Award Contest Launched — TheDay.Com - Educational News
- Professor and his patients 'star' in film — University of Toronto -- News@UofT
- Iowa's Maas wins GSA's 2006 Doris Schwartz Gerontological Nursing Award — EurekAlert! - Medicine and Health
- Pioneer of oral rehydration therapy receives Prince Mahidol Award — EurekAlert! - Medicine and Health
- Vinegar key in new fingerprint method — ORNL in the News
- GSA Bestows Robert W. Kleemeier Award To University Of Virginia's Nessleroade — Health News from Medical News Today
- Higher education briefs — NewsOk.com - NewsOK News
- GSA Confers 2006 Joseph T. Freeman Award To University Of Wisconsin's Carnes — Health News from Medical News Today
- Michael Jackson receives his Diamond Award on stage during ... — Michael Jackson on Yahoo! News Photos
Latest news from FDA News News from StratCenter.com:
- North American Gets Cancer Treatment OK
- North American Scientific Announces FDA Clearance of its ClearPath HDR Breast Brachytherapy System
- Newly FDA Approved SmartLipo Laser Liposuction Available at the Intimate Rejuvenation and Innovative Surgery Center, Phoenix, AZ.
- ACT-AD Coalition Calls FDA's New Focus on Neurological Diseases a Positive 1st Step
- Ivax Diagnostics Delays Filing 3Q Report
- New Corporate Members and Leaders for C-Path's Predictive Safety Testing Consortium Announced
- Diagnosoft Receives FDA Approval for Cardiac MRI Quantitative Regional Function Software Based on the HARP Technology
- PAREXEL Consulting Expands Risk Mgmt Expertise, Appoints Former FDA Consumer Safety Officer Raymond T Oji as Senior Consultant
- Trubion Pharmaceuticals to Present at the Lazard Life Sciences Conference
- Critical Therapeutics Announces Efficacy Data for Controlled-Release Formulation of Zileuton Presented at ACAAI 2006 Annual Meeting